Andrew Baum, M.D., is currently the Chief Strategy and Innovation Officer and Executive Vice President at Pfizer, where they lead portfolio analysis, business development, and partnerships within the biotech ecosystem. Prior to joining Pfizer in 2024, they held the position of Head of Global Healthcare and Managing Director at Citi from 2011 to 2024, and spent fourteen years as Managing Director at Morgan Stanley covering European Pharmaceuticals. Dr. Baum began their career as a practicing physician at the Royal National Orthopaedic Radcliffe Hospital in Oxford after completing their Doctor of Medicine degree at the University of Oxford. They are a Fellow of the Royal Society of Medicine and played a pivotal role in highlighting the transformative potential of cancer immunotherapy in 2011.